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Since the first report of HIV and AIDS in the early 
1980s, the epidemic has continued unabated 
especially in sub-Saharan African countries that 
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ABSTRACT
Background:  In the last decade there had been efforts to halt and reverse the high and increasing trends in 
HIV infection in sub-Saharan Africa. There is need to analyze trends in HIV prevalence to ascertain the 
current course of the HIV epidemic in our society. HIV prevalence among pregnant women attending 
Antenatal Clinics remains the principal data source to inform trends in generalized epidemics in developing 
countries.
Objective:  The aim of this study was to determine the prevalence of HIV and its trends among pregnant 
women attending antenatal clinic at a public tertiary hospital in the Federal Capital Territory, Abuja, Nigeria.
Methods: Data of pregnant women who had HIV test as part of antenatal care between January 2005 and 
December 2009 were prospectively recorded and analyzed to determine the period HIV prevalence and 
trends. 
Results: For the five year period, there was 95% uptake of HIV testing, and out of 8,443 pregnant women 
tested, 973 were sero-positive, giving a period prevalence of 11.5% (CI;10.9%-12.2%). In 2005 HIV 
prevalence was 4.5%, rose to 11.2% in 2006 and peaked at 15.4% in 2009. This trend was statistically 
2significant (÷ -trend=94.1; p<0.001). There was an inverse trend with maternal age with a higher prevalence 
among younger mothers (15-24years) compared to older cohorts (30-49years). This decreasing trend with 
2maternal age was also statistically significant (÷ - trend=5.28; p=0.022). Although HIV prevalence was 
2slightly higher among women with higher parity, this trend was not statistically significant (÷ -trend=0.73; 
p=0.39). HIV prevalence was significantly higher in women in lower social class 1-4, compared with those 
2in higher social class 5 and 6 (÷ - trend=148.7; p<0.0001).
Conclusion: The HIV prevalence among pregnant women is high and showed an increasing trend over the 
five year period. It is an indication of ineffectiveness of measures taken to arrest the scourge over time. This 
has implication for obstetrics practice and may translate to increase in pediatrics HIV/AIDS if adequate 
measures are not taken to prevent mother-to-child transmission. 
Key Words: HIV, Prevalence, Pregnant women, Prevention of mother-to-child transmission of HIV, 
Nigeria.
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harbor about 69% of the 2011 global estimate of 34 
1million infected persons.  With an HIV population of 
about 3.1 million, Nigeria has the second highest 
number of people living with HIV in the world after 
2South Africa.  
Antenatal clinic data have been the primary source of 
information for estimating local and national HIV 
prevalence in countries in sub-Saharan Africa. It is 
also the mainstay for tracking the epidemic in the 
region. While a reliable laboratory based test for 
detection of recent HIV infection that allows 
calculation of HIV incidence is yet to become 
universally available, analysis of surveillance data 
from the same populations over time can provide 
insight into trends of HIV prevalence. HIV 
prevalence among 15-24 year old pregnant women 
has been proposed and used as a proxy measure for 
3incidence.   
Decline in HIV prevalence have been reported from 
some countries with generalized epidemics in recent 
4-9years.  There are however, concerns whether the 
HIV prevalence declines are genuine or the result of 
measurement bias. There are also issues related to the 
possible cause of decline, whether as a result of 
decline in incidence or due to rising mortality rates 
10overtaking the rate of new infections. Some of the  
early reports possibly overestimate or underestimate 
HIV prevalence due to inappropriate site selection 
and quality of laboratory tests and testing strategies. 
The 2006 population of Nigeria was 140 million, 
with a national growth rate of 3-2 percent per 
11annum.  Socio-cultural differences exists among the 
36 States and the Federal Capital Territory. There are 
suggestions of decline in the prevalence of HIV in 
Nigeria following results of 2001, 2003 and 2005 
HIV sero-prevalence study which gave a national 
median prevalence of 5.8%, 5.0% and 4.4% 
12,13respectively.  The trend in decline in HIV 
prevalence was not sustained in the 2008 with a 
14reported national prevalence of 4.6%.  The apparent 
decline in national prevalence may be an artifact 
due to reasons which may include better 
representative ANC surveillance system and testing 
strategies in these later years. There is therefore the 
need for regular monitoring of the HIV situation in 
the country to determine actual trends which may 
vary in different parts of the country.
The on-going Prevention of Mother-to-Child 
transmission of HIV (PMTCT) programme in some 
Nigerian hospitals provides an opportunity to 
properly document and monitor HIV prevalence in 
15the various cities.  We report on the prevalence of 
HIV and its trends from 2005 – 2009 using data of 
pregnant women accessing antenatal clinic of a 
tertiary hospital in the Federal Capital Territory, 
Abuja, Nigeria. The influence  socio-demographic 
variables were also studied.
PATIENTS AND METHODS
Study Setting/Population
This study was conducted at the National Hospital 
Abuja. It is a public tertiary level health facility 
located in the metropolis of the Federal capital 
territory, Abuja, Nigeria. It is a 250 bed hospital 
which commenced service provision in 1999. Its 
services are accessed mainly by residence within 
FCT and nearby Niger and Nasarawa states. 
Because of the central and cosmopolitan site of the 
facility in the federal capital, clients cut across 
tribes, religion, socio-economic status, states and 
geopolitical zones in the country. The department of 
obstetr ics and gynaecology provides a 
comprehensive range of reproductive health care 
services which include antenatal care, delivery care, 
postnatal care, gynecological care, family planning 
and screening for cervical cancer.
Screening for HIV was part of antenatal care from 
inception. This practice was reinforced with the 
commencement of the national PMTCT 
programme in 2002 for which the facility was 
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15among the first 6 centres in the country.  The 
PMTCT programme is implemented in accordance 
16with the National PMTCT guidelines  and PMTCT 
17national standard operating procedures.  It 
essentially involves HIV counseling and testing of 
pregnant women and the provision of interventions 
for HIV positive women to reduce the risk of 
transmitting the infection to the newborn. The 
interventions offered include antiretroviral drug 
prophylaxis and treatment, modification of obstetric 
practice and infant feeding counseling. The infants of 
infected mothers also received ARV prophylaxis, 
expert follow-up and early infant diagnosis. The 
PMTCT programme has been integrated into the 
hospital's obstetrics and pediatrics service.
HIV information/group counseling is offered to all 
new antenatal clients along with routine HIV testing, 
with a right to 'opt out'. In line with the national HIV 
testing guidelines, the HIV-testing strategy utilized 
18during this period was the parallel rapid test.  This 
involves the use of two different types of rapid test on 
all clients. A third 'tie-breaker' rapid test was also 
undertaken when there is discordant result with the 
initial two rapid tests. During the study period 
Capillus® test kit (Trinity –USA) and Genie® test kit 
(BioRad –France) were the test kits used for HIV 
diagnosis. Determine®(Abbot-Japan) was the test 
kit used as 'tie-breaker'. All women who had HIV test 
are offered appropriate post test counseling.
Data Collection and Analysis
Client's age, occupation, parity, gestational age, type 
of counseling, HIV test result were prospectively 
recorded in registers and database that was 
developed to monitor and evaluate the national 
PMTCT programme. The information of women 
who registered and received service between January 
1, 2005 and December 31, 2009 were entered into 
TMEpi-Info  version 3.5.1 statistical software 
19package  and subsequently exported to and analysed 
20using Stata software Release 11.  Combined and 
yearly HIV prevalence with corresponding 95% 
confidence intervals (95% CI) was estimated. The 
HIV prevalence was stratified on selected socio-
demographic variables including maternal age, 
parity and social class. In each stratum, significance 
of the observed time trends in HIV prevalence was 
2determined using the ÷ -test for trends. The level of 
significance was set at p < 0.05.
RESULTS
During the five year period 8,886 pregnant women 
registered for antenatal care and had HIV group 
pretest counseling. Of these, 8,443(95%) accepted 
HIV test and 976 were sero-positive. The period 
HIV prevalence was 11.5% (95% CI; 10.9%-
12.2%). As shown in Table 1, the HIV prevalence 
during the period under consideration showed a 
2rising trend which was statistically significant (÷ -
trend=94.1; p<0.001). HIV prevalence rose from 
4.5% in 2005, to 11.2% in 2006, to 13.3% in 2007, 
and peaked at 15.4% in 2009.
Table 2, shows an inverse trend with maternal age. 
There was higher prevalence among younger 
mothers (15-24years) compared to older cohorts 
(30-49years). This decreasing trend with maternal 
2age was statistically significant (÷ - trend=5.28; 
p<0.022). HIV prevalence was significantly higher 
in women in lower social class 1-4 compared with 
2those in higher social class 5 and 6 (÷ - trend=148.7; 
p<0.001). Although HIV prevalence was slightly 
higher among women with higher parity, this trend 
2was not statistically significant (÷ - trend=0.73; 
p=0.39). 
DISCUSSION 
We have used a five year data (2005-2009) from the 
antenatal clinic in our health facility to document 
the level and trend in HIV prevalence among 
pregnant women in Abuja, Nigeria. We found a 
period prevalence of 11.5% with an increase in 
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prevalence from 4.5% in 2005 to 11.2% in 2006, to 
13.3% in 2007 and 2008 and finally 15.4% in 2009. 
Our finding is indicative of a high and rising trend in 
HIV prevalence in Abuja. The prevalence obtained in 
this study is higher than the 9.9%  obtained in the 
14 sentinel survey conducted in the same city in 2008.
It is also much higher than the national prevalence of 
24.1% obtained in the 2010 national sentinel survey.  
Similarly, higher period prevalence compared with 
sentinel survey report has been recorded from 
21another Nigerian city.  These differences have been 
attributed to the fact that  sentinel surveys are point-
prevalence estimates, obtained bi-annually, and are 
subject to the effect of fluctuations in patient flow, 
whereas in the current report as in other period-
prevalence studies, involves all consenting ANC 
attendees over the entire five-year study period. 
Another probable factor for the higher prevalence in 
this study is the fact that the facility being a referral 
centre and a PMTCT site, receives clients from other 
centers, some of whom are HIV positive. 
Generally, trends in HIV prevalence are related to 
HIV incidence and death rates. We do not have 
information on HIV related mortality rates during 
this period in the population. But we expect the 
contribution of mortality to the observed trend to be 
minimal. Since 2003, there are many facilities within 
and around Abuja that provides HIV treatment, care 
and support under the free antiretroviral treatment 
programme of the Federal government of Nigeria 
with assistance from United States - President's 
Emergency Plan for AIDS Relief (PEPFAR) and 
Global Fund to fight HIV/AIDS, Tuberculosis and 
22,23Malaria (GFATM).  A reliable laboratory based test 
for detection of recent HIV infection that allows 
calculation of HIV incidence will best indicate trend 
in incidence, this is however not available for routine 
use in Nigeria. HIV prevalence in pregnant women 
aged 15-24 years (representing new entrants into the 
reproductive age group) has been used as indicator of 
new infection rate in countries with generalized 
3,24 epidemics. The sustained high prevalence of HIV 
among this age group as seen in this study suggests 
that the rise in the trend of HIV prevalence is 
possibly due to new infections. The finding of rise in 
HIV prevalence in this study is at variance with 
reports from many African countries that 
demonstrated sustained decline in National HIV 
4-8prevalence among ANC clients.  It has been 
established that even in the presence of decline in 
national prevalence there are cities and regions 
within the country that may be experiencing actual 
9increase.
Although, this study did not include information on 
risk factors that could have provided clues to 
explain the observed trend in HIV prevalence, other 
reports have identified the main drivers of the 
epidemic in Nigeria; which include low risk 
perception, high risk behaviors, multiple concurrent 
partners, transactional and intergenerational sex, 
gender inequalities and a lack of an established STI 
23,25programming for most-at-risk persons.  Poor 
knowledge on HIV and AIDS and means of 
prevention is another challenge in the control of the 
disease in the country. The 2013 National 
26Demographic and Health Survey (DHS)  showed 
that only 26% of women aged 15-24 years and 37% 
of men aged 15-24years had a comprehensive 
knowledge of HIV and AIDS. Another possible 
explanation for the high prevalence noted in this 
study was the influx of people from within and 
outside the country into Abuja because of its social, 
political and economic importance as the capital of 
22Nigeria.  
While HIV infection cuts across all social classes 
during the five year period, the prevalence rate was 
significantly lower in women in the higher social 
class 4 and 5. This finding is similar to recent reports 
from Zambia and Uganda that suggest a shift 
towards reduced risk and mortality differentials 
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amongst higher educated younger and older 
27-30antenatal women respectively.  In the early part of 
the HIV epidemic, higher educational attainment and 
socio-economic status were associated with lifestyle 
changes and behaviors that increased the risk of HIV 
29infection.  This relationship however, tend to 
dissolve as the epidemic spreads in any given 
population. The ability to understand and act on 
health promotional messages as well as attitudes that 
influence one's health is linked to educational 
attainment and social class. Highly educated persons 
and those of high social class may be the first to 
respond positively to preventive messages and take 
measures to reduce HIV infections. The relationship 
between social status and HIV infection and other 
associated factors will need to be further investigated 
in order to better understand the dynamics that might 
be associated with the present trend in HIV 
prevalence in Nigeria.
No clear relationship could be established between 
parity and HIV prevalence in the five year period 
studied. HIV prevalence was high in all the parity 
groups. This finding is not in keeping with previous 
21reports from other Nigerian cities. Galadanci et al  
reported decreasing trend of HIV prevalence with 
increasing parity.
CONCLUSION
The HIV prevalence among pregnant women in the 
study is high and showed an increasing trend over the 
five year period. It is an indication that prevention 
and control measures have not achieved the desired 
result. This has implication for obstetrics practice 
and may translate to increase in pediatrics HIV/AIDS 
if adequate measures are not taken to prevent mother-
to-child transmission. There is the need to 
continuously monitor the trends in HIV prevalence in 
the society. This will enable appreciation of the 
burden of the condition, successes in on-going 
interventions and the deployment of more 
appropriate interventions.  There is also the need for 
further studies to identify specific risk factors and 
causes for the increasing trend in HIV in Abuja. 
More HIV preventive initiatives are required to 
stem the increasing prevalence of HIV in our 
society. 
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Table 1 Uptake of Antenatal HIV Counseling and 
Testing by Year of testing 
Year Total
2005 2006 2007 2008 2009


























































Table 2. HIV Sero-prevalence by Year of testing, 
Age group, Social class and Parity.
Characteristics Year Total
2005 2006 2007 2008 2009
P/T  (Prev.) P/T (Prev.) P/T 
(Prev.)




15-19 0/15     (0) 1/14     (13) 3/13     
(23.1)
0/5        (0) 3/11      
(27.3)
7/58          
(12.1)











95/745      
(12.8)




















































>=40 1/31     (3.2)
 
2/34     (5.9)
 
3/28     
(10.7)
 
3/39     
(7.7)
 
1/38      
(2.6)
10/170      
(5.9)




   












0/7        (0) 3/9        
(33.3)
3/10       
(30.0)
2/23     
(8.7)
2/11      
(18.2)




9/155   (5.8) 9/36      
(25.0)
8/38       
(21.1)
















145/810   
(17.9)
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